IndiaTickerLatest filing: General Updates - Piramal Pharma Limited
ObservedCompany dossier
Piramal Pharma
NSE:PPLPHARMA · ISIN INE0DK501011
- Close
- ₹195.68 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Piramal Pharma
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Dec 2024 · revenue ₹2,204.2 Cr · PAT ₹3.7 Cr.
Exchange XBRLLatest ownership: promoter group 34.80% and public 64.72% as of 30 Jun 2026.
Exchange XBRLLatest rating action: Piramal Pharma Limited
Archived reportMaterial events
Open timeline →What changed recently
Observed
Source filing General Updates - Piramal Pharma Limited
NSE · exchange filing
Observed
Source filing Piramal Pharma Ltd - 543635 - Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Grant Of Stock Options
BSE · exchange filing
Observed
Source filing Updates - Piramal Pharma Limited
NSE · exchange filing
Observed
Source filing Piramal Pharma Ltd - 543635 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Temporary Suspension Of Operations At Company'S Facilities Located At Ahmedabad, Gujarat.
BSE · exchange filing
Reported financials
Full financials →31 Dec 2024
- Revenue from operations
- ₹2,204.2 Cr
- Profit after tax
- ₹3.7 Cr
- EPS
- ₹0.03
Observed NSE structured filing · Consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 34.80%
- Public
- 64.72%
- Employee trust
- 0.48%
Observed NSE shareholding XBRL